Artelo Biosciences FY GAAP EPS Falls Short of Expectations
Monday, 25 March 2024, 13:05
Artelo Biosciences Press Release:
Artelo Biosciences reported a FY GAAP EPS of -$3.14, missing the estimate by $0.58. The company had cash and investments totaling $10.4 million as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.